Understand the source comparison
Cerebrolysin Cycle Length: Protocol Comparison
This table compares the most commonly used cerebrolysin cycle protocols across clinical research, detailing the duration, dosing, washout periods, and evidence-based applications for each approach. 10 days 5ml Monday–Friday (weekdays only) 60–90 days Cognitive
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- This table compares the most commonly used cerebrolysin cycle protocols across clinical research, detailing the duration, dosing, washout periods, and evidence-based applications for each approach.
- 10 days
- 5ml
- Monday–Friday (weekdays only)
- 60–90 days
- Cognitive enhancement research, mild cognitive impairment studies, traumatic brain injury acute phase
- Shortest validated cycle. Sufficient for initiating neuroplastic changes but may not allow full synaptic consolidation in chronic neurodegeneration models
- 20 days
- Daily (including weekends)
- Stroke recovery, Alzheimer's disease trials, Parkinson's cognitive dysfunction, post-concussion syndrome
- Most common protocol in published trials. Balances neurotrophic signaling duration with receptor sensitivity preservation
- 30 days
- Daily
- 90–120 days
- Severe neurodegenerative conditions, chronic traumatic encephalopathy, advanced dementia research
- Maximum recommended duration before receptor downregulation becomes significant. Requires extended washout to restore responsiveness
- 10 days (high-dose)
- 10ml
- 90 days
- Acute ischemic stroke (first 7 days post-event), severe TBI, hypoxic brain injury
- Used in emergency neuroprotection research. Higher dose compensates for shorter cycle, requires longer washout